Impact of Interprofessional Collaborative Care on Health Disparities: Roles of Pharmacists in Chronic Disease Management | Chapter 11 | Disease and Health: Research Developments Vol. 9

Background: Interprofessional collaborative care models have shown significant promise in improving clinical outcomes and reducing health disparities in chronic disease management. This study examines the role of interprofessional teams, including pharmacists, and their impact on patient outcomes, health disparities, and economic efficiency.

Methods: This retrospective observational study adhered to STROBE guidelines and analyzed data from a large healthcare institution serving diverse populations. Interprofessional interventions, including medication reconciliation, patient education, and care coordination, were evaluated for their effects on clinical, economic, and disparity-related outcomes.

Results: Collaborative interventions led to significant improvements in HbA1c levels, blood pressure control, and LDL cholesterol reduction. Disparities were notably reduced, with underserved populations experiencing the greatest clinical benefits. Economic analyses revealed cost savings associated with decreased hospitalizations and emergency department visits.

Conclusions: Interprofessional care teams, particularly with pharmacist involvement, play a pivotal role in enhancing chronic disease outcomes, addressing health disparities, and achieving cost efficiency in healthcare delivery.

 

Author (s) Details

Hannah Grace Alex
University of Pittsburgh, Pennsylvania, USA.

 

Nghi Xuan Vo
University of Pittsburgh, Pennsylvania, USA.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrd/v9/5207

A Cross-sectional Study Highlighting Awareness about FDA Announcement on Voluntary Recall of Ranitidine among Physicians and Pharmacists in and Around Chennai, India | Chapter 11 | Current Aspects in Pharmaceutical Research and Development Vol. 8

 Ranitidine is a histamine-2 (H2) blocker that lowers the amount of acid produced by the stomach. The medicine was recalled in September 2019 by the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Health Canada owing to impurities N-nitrosodimethylamine (NDMA). According to laboratory examinations, NDMA is a carcinogen.

The study's goal is to determine how well physicians and pharmacists in and around Chennai are aware of the ranitidine recall announcement and related difficulties.

Materials and Methods: A questionnaire was administered to 198 physicians and 113 pharmacists who were enrolled in the study as part of a descriptive, cross-sectional investigation. The participants' awareness, knowledge, and concerns about recall notification were collected.

Results revealed that only 75% of survey participants were aware of the notification and the difficulties it raised, with urban individuals outnumbering rural ones by a wide margin. When the notification was widely publicised, the grounds for the notification were unknown. The bulk of people who were unfamiliar with the ranitidine recall warning and related difficulties were from rural areas, according to the findings.

Conclusion: The level of awareness among physicians and pharmacists was found to be insufficient. Physicians and pharmacists are the most responsible healthcare practitioners, and they must be aware of any medication-related alerts issued by regulatory agencies.

Author(S) Details

Rukaiah Fatma Begam
Faculty of Pharmacy, SRM Institute of Science and Technology, Chennai 603203, India.

Swathi Suresh
Faculty of Pharmacy, SRM Institute of Science and Technology, Chennai 603203, India.

Yamuna Ravikumar
Faculty of Pharmacy, Vels Institute of Science Technology and Advanced Studies, Chennai, 600117, India.

Deepa Natarajan
Faculty of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Chennai, 602117, India.

Ramaiyan Velmurugan
Faculty of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Chennai, 602117, India.

View Book:- https://stm.bookpi.org/CAPRD-V8/article/view/5652

Exploring the Attitudes and Practices of Pharmacists and Physicians towards Bush Medicine in Guyana| Chapter 6 | Recent Developments in Medicine and Medical Research Vol. 14

 Aims: To investigate physicians' and pharmacists' views and behaviours about bush medicine (including personal use), as well as the factors that influence their attitudes. Also, to see if a video educational intervention has an effect on attitudes.

Introduction: In the Caribbean, the term "bush medicine" refers to medicinal plants that are commonly employed by traditional healers and is considered one part of traditional medicine.

The study used a cross-sectional design with registered physicians and pharmacists.

The study involved a total of 274 people: 134 pharmacists who were attending their first Continuing Pharmacy Education (CPE) of 2015 and 140 physicians who were attending their annual Medical Scientific Conference.

Methodology: A self-administered, pre-tested questionnaire was provided and collected, followed by a video intervention and a post-intervention questionnaire. Latent class cluster analysis was used to analyse the data, and the best-fitting model was selected primarily using the Bayesian Information Criterion (BIC). To evaluate connections with demographic characteristics and the impact of the intervention, researchers used logistic and multinomial regression, as well as Fisher's exact test.

The majority of the participants (56.4 percent) were between the ages of 20 and 30, and the majority (52 percent) had fewer than five years of professional experience. Pharmacists were more enthusiastic about herbal medicine than physicians. Patients should inform their physician/pharmacist about their use of bush medicine, according to the majority (99%), yet just 53% do so on a regular basis. More than half of those polled (52%) had tried bush medicine in the past, but just 38% had ever advocated it. Further than 90% of respondents said that clinical trials with bush medicine should be undertaken before it is utilised, and 88 percent wanted more training. Ethnicity, years of professional experience, and profession influenced views, and the intervention resulted in a more positive opinion about bush medicine.

Conclusion: While most participants expressed reservations about bush medicine, they were eager to learn more and were eager to participate in clinical trials. The content in the movie should be used as a framework for evidence-based clinical research and teaching at the tertiary level or future continuing education sessions.

Author(S) Details

Ede Tyrell
Department of Medical Technology, Faculty of Health Sciences, University of Guyana, Guyana.

Karishma Jeeboo
Department of Pharmacy, Faculty of Health Sciences, University of Guyana, Guyana.

Jewel Edmonson-Carter
Department of Pharmacy, Faculty of Health Sciences, University of Guyana, Guyana.

Troy Thomas
Department of Mathematics, Physics & Statistics, Faculty of Natural Sciences, University of Guyana, Guyana.

Rajini Kurup
Department of Medical Technology, Faculty of Health Sciences, University of Guyana, Guyana.

View Book:- https://stm.bookpi.org/RDMMR-V14/article/view/4984